MAP2K7 and cancer: In addition, there is a dual-target hybrid peptide T10-ERK, which mainly interferes with the binding of MEK and ERK, hinders the activation of ERK (Sheng et al., 2016), inhibits the expression of related nuclear transcription factors to regulate the apoptosis of cancer cells, and achieves the purpose of promoting cancer cell death and overcoming drug resistance.